Dual β-Lactam Combinations Highly Active against Mycobacterium abscessus Complex In Vitro
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual β-Lactam Combinations Highly Active against Mycobacterium abscessus Complex In Vitro
Authors
Keywords
-
Journal
mBio
Volume 10, Issue 1, Pages -
Publisher
American Society for Microbiology
Online
2019-02-11
DOI
10.1128/mbio.02895-18
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ceftazidime-Avibactam Susceptibility Breakpoints Against Enterobacteriaceae and Pseudomonas aeruginosa
- (2018) Wright W. Nichols et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime-Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups
- (2018) Jianguo Li et al. CTS-Clinical and Translational Science
- Mycobacterium abscessus and β-Lactams: Emerging Insights and Potential Opportunities
- (2018) Elizabeth Story-Roller et al. Frontiers in Microbiology
- Nontuberculous mycobacteria in cystic fibrosis: Updates and the path forward
- (2017) Stacey L. Martiniano et al. PEDIATRIC PULMONOLOGY
- British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
- (2017) Charles S Haworth et al. THORAX
- Mycobacterium abscessus Complex Infections in Children: A Review
- (2017) Arick P. Sabin et al. Current Infectious Disease Reports
- Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis
- (2017) Devyani Deshpande et al. Science Advances
- Genome-wide mosaicism within Mycobacterium abscessus: evolutionary and epidemiological implications
- (2016) Guillaume Sapriel et al. BMC GENOMICS
- Mycobacterial Characteristics and Treatment Outcomes inMycobacterium abscessusLung Disease
- (2016) Won-Jung Koh et al. CLINICAL INFECTIOUS DISEASES
- Bactericidal and intracellular activity of β-lactams againstMycobacterium abscessus
- (2016) Anne-Laure Lefebvre et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Inhibition of β-lactamases of mycobacteria by avibactam and clavulanate
- (2016) Daria Soroka et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Non-classical transpeptidases yield insight into new antibacterials
- (2016) Pankaj Kumar et al. Nature Chemical Biology
- PHASTER: a better, faster version of the PHAST phage search tool
- (2016) David Arndt et al. NUCLEIC ACIDS RESEARCH
- Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium
- (2016) Josephine M. Bryant et al. SCIENCE
- Impact of β-Lactamase Inhibition on the Activity of Ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus
- (2015) Vincent Dubée et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
- (2015) R Andres Floto et al. THORAX
- RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies
- (2014) Alexandros Stamatakis BIOINFORMATICS
- Dual beta-lactam therapy for serious Gram-negative infections: is it time to revisit?
- (2014) Christine Rahme et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- -Lactamase inhibition by avibactam in Mycobacterium abscessus
- (2014) V. Dubee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus
- (2014) F. P. Maurer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Rapid Molecular Detection of Inducible Macrolide Resistance in Mycobacterium chelonae and M. abscessus Strains: a Replacement for 14-Day Susceptibility Testing?
- (2014) K. E. Hanson et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins
- (2014) Nicholas J. Croucher et al. NUCLEIC ACIDS RESEARCH
- Characterization of broad-spectrum Mycobacterium abscessus class A -lactamase
- (2013) D. Soroka et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Novel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistance
- (2013) Richard R. Watkins et al. Frontiers in Microbiology
- Mycobacterium abscessus: a new antibiotic nightmare
- (2012) R. Nessar et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41)
- (2012) F. P. Maurer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing
- (2012) Anton Bankevich et al. JOURNAL OF COMPUTATIONAL BIOLOGY
- Proposal that Mycobacterium massiliense and Mycobacterium bolletii be united and reclassified as Mycobacterium abscessus subsp. bolletii comb. nov., designation of Mycobacterium abscessus subsp. abscessus subsp. nov. and emended description of Mycobacterium abscessus
- (2010) S. C. Leao et al. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
- A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae
- (2009) K. A. Nash et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now